Designer Solvents for Pharmaceutics: Role of Ionic Liquids/ Deep Eutectic Solvents in Pharmaceutical Formulations DOI
Diksha Dhiman,

Munirah Alhammadi,

Hanseung Kim

и другие.

Advanced Therapeutics, Год журнала: 2024, Номер 7(8)

Опубликована: Июль 14, 2024

Abstract The design of biologic and synthetic drugs in the pharmaceutical industry is facing three key challenges, namely, ensuring bioavailability, solubility, stability. Ionic liquids (ILs) deep eutectic solvents (DESs), classified as designer solvents, have emerged excellent for improving permeability stability biotherapeutic drugs. Moreover, they shown remarkable solubilizing effects drugs, particularly active ingredients (API), are known eco‐friendly solvents. Thus, this review, development formulations industries reported, underlying strategies designing most efficient both biotherapeutics examined.

Язык: Английский

Polymeric ionic liquids: Here, there and everywhere DOI
Olga Lebedeva, Dmitry Kultin, Л. М. Кустов

и другие.

European Polymer Journal, Год журнала: 2023, Номер 203, С. 112657 - 112657

Опубликована: Дек. 3, 2023

Язык: Английский

Процитировано

12

Protection coatings for corrosion control of mild steel using phenolic polymeric deep eutectic solvents DOI Creative Commons

Jon López de Lacalle,

Daniela Minudri, Matías L. Picchio

и другие.

RSC Sustainability, Год журнала: 2024, Номер 2(6), С. 1809 - 1818

Опубликована: Янв. 1, 2024

Phenolic polymeric deep eutectic solvents form coloured complexes with iron surfaces which can be used as protection coatings for corrosion control of mild steel.

Язык: Английский

Процитировано

5

Polyphenol Iongel Patches with Antimicrobial, Antioxidant and Anti-Inflammatory Properties DOI Open Access
Gisela C. Luque, Melissa Moya, Matías L. Picchio

и другие.

Polymers, Год журнала: 2023, Номер 15(5), С. 1076 - 1076

Опубликована: Фев. 21, 2023

There is an actual need for developing materials wound healing applications with anti-inflammatory, antioxidant, or antibacterial properties in order to improve the performance. In this work, we report preparation and characterization of soft bioactive iongel patches, based on polymeric poly(vinyl alcohol) (PVA) four ionic liquids containing cholinium cation different phenolic acid anions, namely salicylate ([Ch][Sal]), gallate ([Ch][Ga]), vanillate ([Ch][Van]), caffeate ([Ch][Caff]). Within iongels, motif plays a dual role, acting as PVA crosslinker compound. The obtained iongels are flexible, elastic, conducting, thermoreversible materials. Moreover, demonstrated high biocompatibility, non-hemolytic activity, non-agglutination mice blood, which key-sought material specifications applications. All have shown properties, being PVA-[Ch][Sal], one higher inhibition halo Escherichia Coli. also revealed values antioxidant activity due presence polyphenol, PVA-[Ch][Van] having highest activity. Finally, show decrease NO production LPS-stimulated macrophages, PVA-[Ch][Sal] displaying best anti-inflammatory (>63% at 200 µg/mL).

Язык: Английский

Процитировано

11

Piperacillin/Tazobactam Co-Delivery by Micellar Ionic Conjugate Systems Carrying Pharmaceutical Anions and Encapsulated Drug DOI Creative Commons
Katarzyna Niesyto, Aleksy Mazur, Dorota Neugebauer

и другие.

Pharmaceutics, Год журнала: 2024, Номер 16(2), С. 198 - 198

Опубликована: Янв. 30, 2024

Previously obtained amphiphilic graft copolymers based on [2-(methacryloyloxy)ethyl]trimethylammonium chloride (TMAMA) ionic liquid were used as the matrices of three types nanocarriers, i.e., conjugates with piperacillin (PIP) and micelles tazobactam (TAZ), which represented single systems, dual systems bearing PIP anions encapsulated TAZ for co-delivery. The exchange Cl in TMAMA units ones resulted a yield 45.6–72.7 mol.%. self-assembling properties confirmed by critical micelle concentration (CMC), which, after ion exchange, increased significantly (from 0.011–0.020 mg/mL to 0.041–0.073 mg/mL). beneficial encapsulation reach drug loading contents (DLCs) ranges 37.2–69.5 mol.% 50.4–80.4 form particles sizes 97–319 nm 24–192 respectively. In vitro studies indicated that ionically conjugated was released quantities 66–81% (7.8–15.0 μg/mL) from single-drug 21–25% (2.6–3.9 dual-drug systems. release more efficient, achieving 47–98% (7.5–9.0 47–69% (9.6–10.4 ones. Basic cytotoxicity showed non-toxicity polymer matrices, while introduction selected drugs induced against normal human bronchial epithelial cells (BEAS-2B) increase concentration.

Язык: Английский

Процитировано

4

Designer Solvents for Pharmaceutics: Role of Ionic Liquids/ Deep Eutectic Solvents in Pharmaceutical Formulations DOI
Diksha Dhiman,

Munirah Alhammadi,

Hanseung Kim

и другие.

Advanced Therapeutics, Год журнала: 2024, Номер 7(8)

Опубликована: Июль 14, 2024

Abstract The design of biologic and synthetic drugs in the pharmaceutical industry is facing three key challenges, namely, ensuring bioavailability, solubility, stability. Ionic liquids (ILs) deep eutectic solvents (DESs), classified as designer solvents, have emerged excellent for improving permeability stability biotherapeutic drugs. Moreover, they shown remarkable solubilizing effects drugs, particularly active ingredients (API), are known eco‐friendly solvents. Thus, this review, development formulations industries reported, underlying strategies designing most efficient both biotherapeutics examined.

Язык: Английский

Процитировано

4